NARA Discovery
Article Details
← Back to Search Results
Journal Article

New sesquiterpenes from the soft coral Litophyton arboreum

Amany Hamouda Mahmoud; Sabry A. H. Zidan; Mamdouh Nabil Samy; Abdallah Alian; Mahmoud A. A. Ibrahim; Mostafa Ahmed Fouad; Mohamed Salah Kamel; Katsuyoshi Matsunami
Journal of Natural Medicines · Vol. 79, Issue 1 · pp. 162-169 · 2025

Abstract

Two new sesquiterpenes; 8α,11-dihydroxy-β-cyperon ( 2 ), and 5- epi -7α-hydroxy-( +)-oplopanone ( 3 ), were isolated from the soft coral Litophyton arboreum, together with nine known ones, including five sesquiterpenes; 11-hydroxy-8-oxo-β-cyperon ( 1 ), alismoxide ( 4 ), 5β,8β-epidioxy-11-hydroxy-6-eudesmene ( 5 ), chabrolidione B ( 6 ), 7-oxo-tri-nor-eudesm-5-en-4β-ol ( 7 ), two sterols; 7β-acetoxy-24-methyl-cholesta-5,24(28)-diene-3β,19-diol ( 8 ), nebrosteroid M ( 9 ), and two glycerol derivatives; chimyl alcohol ( 10 ) and batyl alcohol ( 11 ). The structures of the isolated compounds were characterized using spectroscopic techniques, predominately HR-ESI–MS, 1D, 2D-NMR, and ECD analyses. Compounds 1 – 11 were evaluated for their cytotoxic activity against three human cancer-cell lines (A549, MCF-7 and HepG2), and anti-leishmanial potential against the causal parasite, Leishmania major. Compounds 4 , 8 , and 9 exhibited potent cytotoxic activity against the A549 cell line (IC 50 = 17.0 ± 2.5, 13.5 ± 2.1, and 16.5 ± 1.3 μg/ml, respectively) as compared with the standard antitumor agent etoposide (IC 50 28.4 ± 4.5 μg/ml). In addition, compound 9 exhibited remarkable cytotoxic activity against MCF-7 cell line (IC 50 = 24.7 ± 2.1 μg/ml: 22.2 ± 4.2 μg/mL for etoposide). Graphical abstract

Bibliographic Information

JournalJournal of Natural Medicines
PublisherSpringer
Publication Date2025-01-01
Publication Year2025
Volume79
Issue1
Pages162-169
Document TypeJournal Article
Print ISSN1340-3443
eISSN1861-0293
DOI10.1007/s11418-024-01843-w

Access Information

NARA Access Coverage2006-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11418
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.